EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metagenomic next-generation sequencing facilitates precision treatment and prognostic improvement in pulmonary cryptococcosis

Yapeng Xu, Jingxuan Miao, Jing Chen, Liqun Ye, Kangli Yang, Hongmin Wang

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1638215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Yapeng Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Cryptococcosis, High-Throughput Nucleotide Sequencing, Metagenomics, Lung Diseases, Fungal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The early diagnosis of pulmonary cryptococcosis (PC) remains challenging due to the low sensitivity and prolonged turnaround time of conventional diagnostic methods. Despite the broad-spectrum pathogen detection capability of metagenomic next-generation sequencing (mNGS), its clinical utility in the diagnosis and therapeutic management of pulmonary cryptococcosis remains underexplored.

Methods

In this retrospective study, 31 patients diagnosed with Cryptococcus infection through mNGS at The First Affiliated Hospital of Zhengzhou University between July 2023 to March 2025 were included. data on clinical characteristics, treatment regimens, and patient prognosis were systematically collected.

Results

Compared to conventional pathogen detection methods, mNGS demonstrated superior sensitivity, shorter turnaround time (1.00 d vs. 4.50 d, p = 0.002), and significantly reduced interval from admission to clinical decision-making (3.50 d vs. 9.00 d, p = 0.002). Among 31 patients with mNGS-identified cryptococcal infection, only 12 underwent fungal culture, with merely 1 case yielding positive results (positivity rate: 8.33%). Antimicrobial therapy was optimized for all patients based on mNGS findings. During post-discharge follow-up of 27 cases, 1 patient experienced disease recurrence, 1 died from tumor metastasis, and 1 was lost to follow-up.

Conclusion

Our retrospective analysis revealed that mNGS facilitated treatment optimization, improved clinical outcomes, and provided crucial evidence supporting the precision management of pulmonary cryptococcosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptococcosisHigh-Throughput Nucleotide SequencingMetagenomicsLung Diseases, FungalCryptococcusHumansMaleRetrospective StudiesFemaleMiddle AgedPrognosisAgedAntifungal AgentsAdultSensitivity and Specificity

Stichwörter der Autor:innen

diagnosismetagenomic next-generation sequencingprognosispulmonary cryptococcosistreatment

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Xu, Y., Miao, J., Chen, J., Ye, L., Yang, K., & Wang, H. (2025). Metagenomic next-generation sequencing facilitates precision treatment and prognostic improvement in pulmonary cryptococcosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1638215

Vancouver

Xu Y, Miao J, Chen J, Ye L, Yang K, Wang H. Metagenomic next-generation sequencing facilitates precision treatment and prognostic improvement in pulmonary cryptococcosis. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1638215

BibTeX
@article{Xu2025,
  author = {Xu, Yapeng and Miao, Jingxuan and Chen, Jing and Ye, Liqun and Yang, Kangli and Wang, Hongmin},
  title = {Metagenomic next-generation sequencing facilitates precision treatment and prognostic improvement in pulmonary cryptococcosis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1638215}
}
Kostenlos starten →